Statin therapy in the treatment of Alzheimer disease: what is the rationale?

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2001 • 24,089 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2002 • 6,780 citations

The Cholinergic Hypothesis of Geriatric Memory Dysfunction

1982 • 5,422 citations

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

2004 • 4,752 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

2003 • 3,816 citations

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

2003 • 2,264 citations

Memantine in Moderate-to-Severe Alzheimer's Disease

2003 • 1,889 citations

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1998 • 1,795 citations

Statins and the risk of dementia

2000 • 1,741 citations

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

1989 • 1,630 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

2001 • 1,567 citations

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

2000 • 1,415 citations

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

2004 • 1,350 citations

EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

2005 • 1,314 citations

APRIORITY

1961 • 1,293 citations

Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons

1998 • 1,139 citations

Prevalence of Alzheimer's Disease in a Community Population of Older Persons

1989 • 1,128 citations

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

2001 • 1,083 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

1998 • 669 citations

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

2000 • 609 citations

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

2004 • 539 citations

Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People

2002 • 519 citations

Commentary: Another piece of the Alzheimer's jigsaw

1999 • 502 citations

The Public Health Impact of Alzheimer's Disease, 2000–2050: Potential Implication of Treatment Advances

2002 • 449 citations

Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women

2002 • 432 citations

ADAMs family members as amyloid precursor protein α‐secretases

2003 • 430 citations

Epidemiology of Dementia and Alzheimer's Disease

1998 • 410 citations

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke

1999 • 394 citations

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

2003 • 309 citations

The Women’s Health Initiative Memory Study (WHIMS)

1998 • 300 citations

Cholesterol and Alzheimer’s disease

2001 • 258 citations

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease

2001 • 254 citations

Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol

2002 • 222 citations

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin

1997 • 208 citations

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

1982 • 200 citations

Aβ-peptides enhance vasoconstriction in cerebral circulation

2001 • 192 citations

Current Concepts in the Pathogenesis of Alzheimer’s Disease

1997 • 139 citations

Role of the Low-density Lipoprotein Receptor–Related Protein in β-Amyloid Metabolism and Alzheimer Disease

2000 • 103 citations

Links Between the Pathology of Alzheimer's Disease and Vascular Dementia

2004 • 101 citations

HMG‐CoA reductase inhibition protects the diabetic myocardium from ischemia‐reperfusion injury

2001 • 99 citations

Long‐term efficacy and safety of galantamine in patients with mild‐to‐moderate Alzheimer's disease: multicenter trial

2004 • 95 citations

Cytotoxic Fragment of Amyloid Precursor Protein Accumulates in Hippocampus after Global Forebrain Ischemia

1996 • 83 citations

Tau, where are we now?

2002 • 76 citations

Vascular aspects in Alzheimer’s disease

2000 • 73 citations

HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?

2003 • 65 citations

Cholesterol and Alzheimer's disease

2002 • 64 citations

The west of Scotland Coronary Prevention study: A trial of cholesterol reduction in scottish men

1995 • 57 citations

Atorvastatin improves endothelial function in renal‐transplant recipients

2001 • 56 citations

Untitled

2003 • 29 citations

The Role of Cardiovascular Risk Factors in Alzheimer's Disease

2003 • 21 citations

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

2000 • 10 citations

Emerging Therapeutics for Alzheimer's Disease: An Avenue of Hope

2003 • 8 citations

Deleted Work

1955 • 0 citations